Send email for updates
Day E., Strang J.
Journal of Substance Abuse Treatment: 2011, 40, p. 56–66.
Unable to obtain a copy by clicking title? Try asking the author for a reprint by adapting this prepared e-mail or by writing to Dr Day at firstname.lastname@example.org.
Methadone maintained heroin-dependent patients in Birmingham (UK) randomised to inpatient v. outpatient lofexidine-based detoxification rarely sustained long-term opioid abstinence; return to maintenance was the typical outcome.
Summary Opioid detoxification is not an effective stand-alone treatment for heroin dependence but is nevertheless an essential step in the path to recovery. There has been relatively little previous controlled research on the impact of treatment setting on the likelihood of successful completion of detoxification. In this study, 68 opioid-dependent patients receiving community treatment (predominantly with methadone) and requesting detoxification were randomly assigned to an inpatient versus outpatient setting. Both groups received the same medication (lofexidine), and the primary outcome measure was being opioid-free at detoxification completion. More inpatients (51.4%) than outpatients (36.4%) completed detoxification, but this difference was not statistically significant. However, the outpatient group received a significantly longer period of medication, and when the length of detoxification was controlled for, the results significantly favoured the inpatient setting. Only 11 (16%) participants were opioid-free at the 1-month follow-up and 8 at the 6-month follow-up, with no between-group difference. Inpatient and outpatient opioid detoxification settings were not significantly different in completion or follow-up abstinence rates, but aspects of the study design may have favoured the outpatient setting. Future studies should test patient characteristics that predict better outcomes in each setting.
Last revised 04 February 2011
Comment/query to editor
Give us your feedback on the site (one-minute survey)
Open Effectiveness Bank home page
Add your name to the mailing list to be alerted to new studies and other site updates
MATRIX CELL 2014 Drug Matrix cell A2: Interventions; Generic and cross-cutting issues
DOCUMENT 2014 Time limiting opioid substitution therapy